Physician

James Patrick Anderson, M.D.

According to 2025 Medicare claims, James Anderson, M.D. (NPI: 1689671802) practices neurology in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Montgomery, TN. Anderson uses personal NPI as billing NPI and primary practice location at 37043-4539.

Anderson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 597 traditional Medicare patients, billed 4,038 HCPCS/CPT codes, and received $299,636 in Medicare payments. The top billing code was 95913 (Nerve conduction, 13 or more studies). Part D data shows 8,751 prescription claims across 881 beneficiaries totaling $1,223,429 in drug costs, led by Ingrezza (Valbenazine Tosylate). DME data shows 332 claims. Open Payments data shows 179 records totaling $2,883. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $324,988 to $299,636. In contrast, Part D prescription costs have moved sharply higher in recent years, from $400,119 to $1,223,429. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $29,475 and ending at $29,892.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	596	4,019	$324,988
2016	539	3,309	$1,123,162
2017	559	4,177	$1,917,356
2018	557	4,017	$805,063
2019	569	4,209	$308,934
2020	517	3,355	$262,023
2021	540	3,591	$323,788
2022	509	3,619	$300,770
2023	549	3,788	$310,836
2024	597	4,038	$299,636

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	403	2,910	$400,119
2016	340	2,804	$516,393
2017	357	2,747	$712,499
2018	355	2,478	$719,166
2019	404	2,416	$296,306
2020	477	2,598	$239,246
2021	591	3,688	$245,386
2022	708	4,939	$571,215
2023	782	6,170	$1,293,994
2024	881	8,751	$1,223,429

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	295	572	$28,655
2016	135	358	$12,832
2017	126	434	$12,688
2018	164	485	$24,955
2019	230	470	$43,051
2020	321	605	$48,074
2021	186	439	$19,745
2022	133	376	$14,939
2023	165	405	$17,335
2024	153	332	$11,727

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95913	Nerve conduction, 13 or more studies	94	94	$190
95912	Nerve conduction, 11-12 studies	163	163	$160
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	163	163	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	430	1,524	$78
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	267	588	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ingrezza	Valbenazine Tosylate	33	990	$272,120
Xcopri	Cenobamate	117	2,642	$151,475
Briviact	Brivaracetam	47	1,400	$67,979
Aptiom	Eslicarbazepine Acetate	32	960	$49,737
Nurtec Odt	Rimegepant Sulfate	30	793	$34,613

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7032	Cushion for use on nasal mask interface, replacement only, each	N	12	34	$2,468
A7030	Full face mask used with positive airway pressure device, each	N	13	26	$2,061
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	16	36	$1,713
A7031	Face mask interface, replacement for full face mask, each	N	12	24	$1,645
E0601	Continuous positive airway pressure (cpap) device	Y	12	61	$1,565

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	179	$2,883	Neurocrine Biosciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Patrick Anderson, M.D.?

Tedicare shows public-source Medicare data for James Patrick Anderson, M.D. (NPI 1689671802), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Patrick Anderson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Patrick Anderson, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does James Patrick Anderson, M.D. have Open Payments data?

James Patrick Anderson, M.D. has 179 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.